Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Open Framework Agreement On Pharmaceutical Discounts In Accordance With Section 130a (8) Sgb V With Any Time, So -called Registration Model 202507 2026-01-17
Germany Conclusion Of Non-exclusive Discounts Agreements Pursuant To § 130a, Paragraph 8, Sgb V On The Aforementioned Active Substances With Conclusion Possibility Within The Framework Of The So-called Openhouse Procedure. 2026-01-17
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2026-01-18
Germany Completion Of A Non -exclusive Discount Contract According To § 130a Para. 8 Sgb V To Medicines With The Active Ingredient Omalizumab (atccode 2026-01-18
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2026-01-18
Bulgaria "delivery Of Medicinal Products For The Needs Of Psagbal St. Sofia Ead For The Period 20252027" 2026-01-18
France Dynamic Acquisition System For Class L Medications (18.07 Immunomodulatory Antiplastic) And Class N (18.09 Nervous System) Of The Gcs Pharma Hauts-de-france 2026-01-19
Portugal Acquisition Of Health Services For Psp Clinical Posts And Medical Boards For The Three-year Period 2025 To 2027 2026-01-19
France Acquisition Of Medical Devices And Biomedical Equipment For The Benefit Of Eda Customers (application Phase) 2026-01-19
Germany Open House Original Discount Contracts 202523 Rilpivirin (dosage Form 2026-01-19
Whats app